Search Results Search Sort by RelevanceMost Recent Medicine and Society Feb 2004 Physician Autonomy, Paternalism, and Professionalism: Finding Our Voice Amid Conflicting Duties Geoffrey C. Williams, MD, PhD and Timothy E. Quill, MD Rules of managed health care and the demand for high physician productivity have harmed patients' ability to make informed, autonomous decisions. Virtual Mentor. 2004;6(2):113-117. doi: 10.1001/virtualmentor.2004.6.2.msoc2-0402. In the Literature Sep 2004 Agents of a Rogue State? Physicians' Participation in State-Sponsored Torture Meme Wang, MPH The participation of physicians in torture around the world exposes the ineffectiveness of international declarations that condemn the practice. Virtual Mentor. 2004;6(9):395-397. doi: 10.1001/virtualmentor.2004.6.9.jdsc1-0409. Medical Education Sep 2004 Integrating Human Rights into Medical Education Kari Hannibal, Carola Eisenberg, MD, and H. Kristian Heggenhougen, PhD Educating medical students, residents, and practicing physicians about human rights can help them become more effective advocates for patients. Virtual Mentor. 2004;6(9):398-400. doi: 10.1001/virtualmentor.2004.6.9.medu1-0409. In the Literature May 2003 Does Medical Uncertainty Justify Medical Paternalism? Jeremy Spevick Physicians need to understand when it may be appropriate to let patients get involved in medical decision-making and when it may be necessary to provide their personal medical judgment. Virtual Mentor. 2003;5(5):170-173. doi: 10.1001/virtualmentor.2003.5.5.jdsc1-0305. Medicine and Society Jul 2024 How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder? Elizabeth Salisbury-Afshar, MD, MPH, Catherine J. Livingston, MD, MPH, and Ricky N. Bluthenthal, PhD Equity requires full access to evidence-based OUD care, housing stability, and education and employment opportunities. AMA J Ethics. 2024;26(7):E562-571. doi: 10.1001/amajethics.2024.562. Policy Forum Jul 2024 How Should the Use of Opioids Be Regulated to Motivate Better Clinical Practice? Ellen L. Edens, MD, MPE, MA, Gabriela Garcia Vassallo, MD, and Robert Heimer, PhD Reconsider regulatory and clinical frameworks for prescribing long-term opioid therapy for pain and prescribing opioids to treat OUD. AMA J Ethics. 2024;26(7):E551-561. doi: 10.1001/amajethics.2024.551. In the Literature Jul 2024 How Should Harm Reduction Strategies Differ for Adolescents and Adults? Brady J. Heward, MD, Amy M. Yule, MD, and Peter R. Jackson, MD Recent increases in adolescent mortality from overdose have outpaced increases in mortality in members of the general population. AMA J Ethics. 2024;26(7):E534-545. doi: 10.1001/amajethics.2024.534. Case and Commentary Jul 2024 How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD? Kathryn A. Dong, MD, MSc and Katherine M. Duthie, PhD, HEC-C Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary. AMA J Ethics. 2024;26(7):E512-519. doi: 10.1001/amajethics.2024.512. History of Medicine Jul 2024 Drawing on Black and Queer Communities’ Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies Sterling Johnson, JD, MA and Kimberly L. Sue, MD, PhD Black and queer community-based harm reduction practices can help guide development and implementation of anti-overdose interventions. AMA J Ethics. 2024;26(7):E580-586. doi: 10.1001/amajethics.2024.580. Case and Commentary Jul 2024 When Are “Paraphernalia” Critical Medical Supplies? Adriane M. dela Cruz, MD, PhD, Donald Egan, MD, MPH, Sarah E. Baker, MD, MA, and John Z. Sadler, MD Evidence of harm reduction interventions’ morbidity and mortality benefits is abundant and of high quality. AMA J Ethics. 2024;26(7):E527-533. doi: 10.1001/amajethics.2024.527. Pagination First page « First Previous page ‹ Previous … Page 21 Page 22 Page 23 Page 24 Page 25 Page 26 Current page 27 Page 28 Page 29 Next page Next › Last page Last »
Medicine and Society Feb 2004 Physician Autonomy, Paternalism, and Professionalism: Finding Our Voice Amid Conflicting Duties Geoffrey C. Williams, MD, PhD and Timothy E. Quill, MD Rules of managed health care and the demand for high physician productivity have harmed patients' ability to make informed, autonomous decisions. Virtual Mentor. 2004;6(2):113-117. doi: 10.1001/virtualmentor.2004.6.2.msoc2-0402.
In the Literature Sep 2004 Agents of a Rogue State? Physicians' Participation in State-Sponsored Torture Meme Wang, MPH The participation of physicians in torture around the world exposes the ineffectiveness of international declarations that condemn the practice. Virtual Mentor. 2004;6(9):395-397. doi: 10.1001/virtualmentor.2004.6.9.jdsc1-0409.
Medical Education Sep 2004 Integrating Human Rights into Medical Education Kari Hannibal, Carola Eisenberg, MD, and H. Kristian Heggenhougen, PhD Educating medical students, residents, and practicing physicians about human rights can help them become more effective advocates for patients. Virtual Mentor. 2004;6(9):398-400. doi: 10.1001/virtualmentor.2004.6.9.medu1-0409.
In the Literature May 2003 Does Medical Uncertainty Justify Medical Paternalism? Jeremy Spevick Physicians need to understand when it may be appropriate to let patients get involved in medical decision-making and when it may be necessary to provide their personal medical judgment. Virtual Mentor. 2003;5(5):170-173. doi: 10.1001/virtualmentor.2003.5.5.jdsc1-0305.
Medicine and Society Jul 2024 How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder? Elizabeth Salisbury-Afshar, MD, MPH, Catherine J. Livingston, MD, MPH, and Ricky N. Bluthenthal, PhD Equity requires full access to evidence-based OUD care, housing stability, and education and employment opportunities. AMA J Ethics. 2024;26(7):E562-571. doi: 10.1001/amajethics.2024.562.
Policy Forum Jul 2024 How Should the Use of Opioids Be Regulated to Motivate Better Clinical Practice? Ellen L. Edens, MD, MPE, MA, Gabriela Garcia Vassallo, MD, and Robert Heimer, PhD Reconsider regulatory and clinical frameworks for prescribing long-term opioid therapy for pain and prescribing opioids to treat OUD. AMA J Ethics. 2024;26(7):E551-561. doi: 10.1001/amajethics.2024.551.
In the Literature Jul 2024 How Should Harm Reduction Strategies Differ for Adolescents and Adults? Brady J. Heward, MD, Amy M. Yule, MD, and Peter R. Jackson, MD Recent increases in adolescent mortality from overdose have outpaced increases in mortality in members of the general population. AMA J Ethics. 2024;26(7):E534-545. doi: 10.1001/amajethics.2024.534.
Case and Commentary Jul 2024 How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD? Kathryn A. Dong, MD, MSc and Katherine M. Duthie, PhD, HEC-C Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary. AMA J Ethics. 2024;26(7):E512-519. doi: 10.1001/amajethics.2024.512.
History of Medicine Jul 2024 Drawing on Black and Queer Communities’ Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies Sterling Johnson, JD, MA and Kimberly L. Sue, MD, PhD Black and queer community-based harm reduction practices can help guide development and implementation of anti-overdose interventions. AMA J Ethics. 2024;26(7):E580-586. doi: 10.1001/amajethics.2024.580.
Case and Commentary Jul 2024 When Are “Paraphernalia” Critical Medical Supplies? Adriane M. dela Cruz, MD, PhD, Donald Egan, MD, MPH, Sarah E. Baker, MD, MA, and John Z. Sadler, MD Evidence of harm reduction interventions’ morbidity and mortality benefits is abundant and of high quality. AMA J Ethics. 2024;26(7):E527-533. doi: 10.1001/amajethics.2024.527.